| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Remmel H. Lawrence is a Director at ATOS. Recent filings cover 4 purchases and 0 sales.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | ATOS Atossa Therapeutics, Inc. | Director | Buy | 10,000 | $0.70 | $7,000.00 | +3,891% | +18.6% | -54.9% | |
| Apr 17, 2017 | ATOS Atossa Therapeutics, Inc. | Director | Buy | 2,500 | $0.63 | $1,580.00 | +399.4% | - | - | |
| Apr 1, 2016 | ATOS Atossa Therapeutics, Inc. | Director | Buy | 1,500 | $0.33 | $495.00 | +16.0% | - | - | |
| Jun 12, 2015 | ATOS Atossa Therapeutics, Inc. | Director | Buy | 5,400 | $1.30 | $7,020.00 | +135.0% | - | - |